Abstract Rapid and precise molecular diagnostics for common chromosomal aneuploidies are in high demand due to the extensive use of genetic testing in high-risk pregnancies. Here, we demonstrate that trisomy 21 (Down syndrome), the most prevalent aneuploidy in humans, can be accurately...
Rapid and precise molecular diagnostics for common chromosomal aneuploidies are in high demand due to the extensive use of genetic testing in high-risk pregnancies. Here, we demonstrate that trisomy 21 (Down syndrome), the most prevalent aneuploidy in humans, can be accurately measured using digital polymerase chain reaction (dPCR). Any aneuploidy can be treated with dPCR, which is also capable of detecting signals in the presence of mosaicism or contaminated maternal DNA. It is also independent of allelic distribution or gender.
Although there are 46 chromosomes in the human genome, there can occasionally be more or fewer chromosomes present. This is known as aneuploidy, which is a general word used to explain the source of such disorders rather than a specific ailment.
In a growing embryo, aneuploidy develops when the chromosomes do not properly divide during cell division. Genes that could result in genetic illnesses, birth deformities, and diseases could be absent, extra, or mutated in these defective chromosomes. Genetic inheritance or chance can also cause aneuploidy. Down syndrome, which is defined by excess genetic material from chromosome 21, is the most prevalent disorder that arises from aneuploidy in humans.
Aneuploidy testing is not a diagnostic procedure. Instead, it is a preliminary determination of whether or not a foetus is more likely than not to have genetic diseases. More diagnostic testing, however, will be required in the event that screening reveals a moderate or high risk for genetic issues.
There is no need for waiting, and women should have access to trustworthy information about their pregnancies as soon as screening permits because chromosomal disorders manifest in the earliest stages of foetal development.
All pregnant women are urged to get the testing regardless of whether their family has a history of genetic abnormalities, even though many chromosomal disorders are not inherited. Because aneuploidy can develop in any pregnancy, regardless of prior healthy pregnancies, women who have had normal pregnancies should still think about getting screened.
Aneuploidy screening without surgery is secure and simple. If additional testing is required, it can be determined from a blood sample obtained between the eleventh and fourteenth week of pregnancy. There are also certain ultrasounds that search for anatomical clues.
|Test Type||Includes||Preparation||Reporting||Test Price|
|Chromosome Analysis for Aneuploidy Detection||
Chromosome Analysis for Aneuploidy Detection (Pathology Test)
Within 24 hours*
Early check ups are always better than delayed ones. Safety, precaution & care is depicted from the several health checkups. Here, we present simple & comprehensive health packages for any kind of testing to ensure the early prescribed treatment to safeguard your health.